Fenkci V - Search Results

1

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.

Fenkci V, Fenkci S, Yilmazer M, Serteser M. Fenkci V, et al. Among authors: fenkci s. Fertil Steril. 2003 Jul;80(1):123-7. doi: 10.1016/s0015-0282(03)00571-5. Fertil Steril. 2003. PMID: 12849813 Free article.

2

QT dispersion in patients with polycystic ovary syndrome.

Alpaslan M, Onrat E, Yilmazer M, Fenkci V. Alpaslan M, et al. Among authors: fenkci v. Jpn Heart J. 2002 Sep;43(5):487-93. doi: 10.1536/jhj.43.487. Jpn Heart J. 2002. PMID: 12452306 Free article.

3

Serum HLA-G levels in women with polycystic ovary syndrome.

Oztekin O, Fenkci SM, Fenkci V, Enli Y, Cabus U. Oztekin O, et al. Among authors: fenkci v. Gynecol Endocrinol. 2015 Mar;31(3):243-6. doi: 10.3109/09513590.2014.982084. Epub 2014 Nov 18. Gynecol Endocrinol. 2015. PMID: 25403326 Free article.

4

Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension.

Fenkci S, Fenkci V, Yilmazer M, Serteser M, Koken T. Fenkci S, et al. Among authors: fenkci v. Hum Reprod. 2003 Apr;18(4):866-70. doi: 10.1093/humrep/deg146. Hum Reprod. 2003. PMID: 12660287

5

Have Ureaplasma urealyticum and Mycoplasma hominis infections any significant effect on women fertility?

Fenkci V, Yilmazer M, Aktepe OC. Fenkci V, et al. Infez Med. 2002 Dec;10(4):220-3. Infez Med. 2002. PMID: 12754428 Free article.

6

Effects of short-time (3 months) tibolone treatment on bone turnover in postmenopausal women.

Fenkci V, Yilmazer M, Fenkci S. Fenkci V, et al. Among authors: fenkci s. Arch Gynecol Obstet. 2003 Jun;268(2):85-7. doi: 10.1007/s00404-002-0345-0. Epub 2002 Aug 21. Arch Gynecol Obstet. 2003. PMID: 12768295

7

Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women.

Yilmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Yilmazer M, et al. Among authors: fenkci s, fenkci v. Hum Reprod. 2003 Jul;18(7):1531-5. doi: 10.1093/humrep/deg292. Hum Reprod. 2003. PMID: 12832384

8

The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.

Fenkci V, Yilmazer M, Alpaslan M, Onrat E, Fenkci S. Fenkci V, et al. Among authors: fenkci s. Gynecol Obstet Invest. 2003;55(3):139-44. doi: 10.1159/000071527. Gynecol Obstet Invest. 2003. PMID: 12865592 Clinical Trial.

9

Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.

Yilmazer M, Fenkci V, Fenkci S, Sonmezer M, Aktepe O, Altindis M, Kurtay G. Yilmazer M, et al. Among authors: fenkci s, fenkci v. Maturitas. 2003 Dec 10;46(4):245-53. doi: 10.1016/s0378-5122(03)00217-2. Maturitas. 2003. PMID: 14625121 Clinical Trial.

10

Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.

Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Fenkci SM, et al. Among authors: fenkci v. Hum Reprod. 2008 Jul;23(7):1602-6. doi: 10.1093/humrep/den109. Epub 2008 Mar 31. Hum Reprod. 2008. PMID: 18378560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters